196.15 -5.70 (-2.82%)
NSEMar 05, 2021 03:31 PM
Latest broker research reports with buy, sell, hold recommendations along with forecast target prices and upside. Browse thousands of reports and search by company or the broker.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2017-10-25||Panacea Biotec Ltd. +||Rudra Shares and Stock Brokers Ltd||240.30||310.00||240.30 (-18.37%)||Target met||Buy|
Rudra Shares and Stock Brokers Ltd
Robust product pipeline of promising niche products to fuel long term future growth, Strong Product Portfolio with significant brand market share in respective therapeutic segment, PANACEA is amongst the top 50 innovators in India with strong foundation of over two decades. Eyeing on Recent updates & highlights Amongst 6 WHO pre-qualified Suppliers of pentavalent vaccine US ANDAs - 3 approved; 3 pending for approval; 23 under development...